Stage IIA Esophageal Adenocarcinoma
1 clinical trials · Condition
◉ Watch Stage IIA Esophageal Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy (NCT02392377) | Case Comprehensive Cancer Center | 2015-02-01 |
Track Stage IIA Esophageal Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.